These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12476078)

  • 21. Risk factors associated with irreversible airflow limitation in asthma.
    ten Brinke A
    Curr Opin Allergy Clin Immunol; 2008 Feb; 8(1):63-9. PubMed ID: 18188020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mannitol and AMP do not induce bronchoconstriction in eosinophilic bronchitis: further evidence for dissociation between airway inflammation and bronchial hyperresponsiveness.
    Singapuri A; McKenna S; Brightling CE; Bradding P
    Respirology; 2010 Apr; 15(3):510-5. PubMed ID: 20210888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma.
    Gibson PG; Saltos N; Borgas T
    J Allergy Clin Immunol; 2000 Apr; 105(4):752-9. PubMed ID: 10756226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic significance of chronic bronchitis in the development of reversible and irreversible chronic airflow limitation.
    Nugent K
    Semin Respir Infect; 1994 Mar; 9(1):3-7. PubMed ID: 7973164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Airway wall remodeling: friend or foe?
    McParland BE; Macklem PT; Pare PD
    J Appl Physiol (1985); 2003 Jul; 95(1):426-34. PubMed ID: 12794101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent peripheral airway obstruction in children with severe asthma.
    Akhter J; Gaspar MM; Newcomb RW
    Ann Allergy; 1989 Jul; 63(1):53-8. PubMed ID: 2742216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is the role of bronchial thermoplasty in the management of severe asthma?
    O'Reilly A; Lane S
    Ther Adv Respir Dis; 2018; 12():1753466618792410. PubMed ID: 30132377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trefoil factor-2 reverses airway remodeling changes in allergic airways disease.
    Royce SG; Lim C; Muljadi RC; Samuel CS; Ververis K; Karagiannis TC; Giraud AS; Tang ML
    Am J Respir Cell Mol Biol; 2013 Jan; 48(1):135-44. PubMed ID: 22652198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of lung inflation in airway hyperresponsiveness and in asthma.
    Scichilone N; Togias A
    Curr Allergy Asthma Rep; 2004 Mar; 4(2):166-74. PubMed ID: 14769267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of airway remodeling in asthma.
    Tagaya E; Tamaoki J
    Allergol Int; 2007 Dec; 56(4):331-40. PubMed ID: 17965576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood lipid levels associate with childhood asthma, airway obstruction, bronchial hyperresponsiveness, and aeroallergen sensitization.
    Vinding RK; Stokholm J; Chawes BLK; Bisgaard H
    J Allergy Clin Immunol; 2016 Jan; 137(1):68-74.e4. PubMed ID: 26148797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma.
    Chetta A; Foresi A; Del Donno M; Consigli GF; Bertorelli G; Pesci A; Barbee RA; Olivieri D
    Am J Respir Crit Care Med; 1996 Mar; 153(3):910-7. PubMed ID: 8630572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remodeling in asthma and chronic obstructive lung disease.
    Jeffery PK
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S28-38. PubMed ID: 11734464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness.
    Burgess JK; Boustany S; Moir LM; Weckmann M; Lau JY; Grafton K; Baraket M; Hansbro PM; Hansbro NG; Foster PS; Black JL; Oliver BG
    Am J Respir Crit Care Med; 2010 Jan; 181(2):106-15. PubMed ID: 19875687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiologic evaluation of asthma.
    Kamp DW
    Chest; 1992 Jun; 101(6 Suppl):396S-400S. PubMed ID: 1591938
    [No Abstract]   [Full Text] [Related]  

  • 36. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease.
    Jeffery PK
    Proc Am Thorac Soc; 2004; 1(3):176-83. PubMed ID: 16113432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchial epithelium as a target for innovative treatments in asthma.
    Gras D; Chanez P; Vachier I; Petit A; Bourdin A
    Pharmacol Ther; 2013 Dec; 140(3):290-305. PubMed ID: 23880290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Destruction of the bronchial epithelium in patients with severe asthma according to different patterns of inflammation and cold airway hyperresponsiveness.
    Pirogov AB; Gassan DA; Zinov'ev SS; Prikhodko AG; Kolosov VP; Perelman JM
    Ter Arkh; 2019 Mar; 91(3):31-35. PubMed ID: 31094456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measuring bronchitis in airway diseases: clinical implementation and application: Airway hyperresponsiveness in asthma: its measurement and clinical significance.
    Nair P; Hargreave FE
    Chest; 2010 Aug; 138(2 Suppl):38S-43S. PubMed ID: 20668016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation between small airway obstruction and bronchial responsiveness in patients with bronchial asthma and chronic bronchitis].
    Hoshino S
    Arerugi; 1986 Nov; 35(11):1079-87. PubMed ID: 3827602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.